Skip to main content
FDA Shortage Check

Is Dextrose Monohydrate 50% Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Dextrose Monohydrate 50% Inject…: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated Recovery: December 2026”. Manufacturer’s estimate, Hospira, Inc., a Pfizer Company, Oct 21, 2026
DRUG
Dextrose Monohydrate 50% Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Jan 13, 2022
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 3 presentations: 1 unavailable · 2 limited · 0 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Dextrose Monohydrate 50% Injection. 4 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Amphastar Pharmaceuticals, Inc.1 presentation · 1 limited

Contact (FDA's listing): 800-423-4136

  • 25 g/50 mL

    Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)

    NDC 76329-3302-1Reverified

    Limited Availability

Hospira, Inc., a Pfizer Company2 presentations · 1 unavailable · 1 limited

Contact (FDA's listing): 844-646-4398

  • 25 g/50 mL

    Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)

    Next Delivery: October 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-7517-16Revised

    Unavailable

  • 25 g/50 mL

    Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)

    Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-6648-02Revised

    Limited Availability

What the manufacturers told FDA

  • Hospira, Inc., a Pfizer Company · ‘Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Next Delivery: October 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Other products with the same ingredient and form

A discontinuation “does not necessarily create a shortage” (FDA).

  • Hospira, Inc., a Pfizer Company told FDA it will discontinue Dextrose Monohydrate 50% (posted ).

    “Discontinuation of the manufacture of the drug”

    FDA listing: Dextrose Monohydrate 50% Injection

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Dextrose Monohydrate 50% Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Dextrose Monohydrate 50% Injection as currently in shortage: 3 presentations, 1 unavailable and 2 limited.
When will the Dextrose Monohydrate 50% Injection shortage end?
FDA gives no end date. 2 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Dextrose Monohydrate 50% Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.